Christoph H. Westphal, President and CEO at Flex Pharma, Inc. (FLKS), bought 28,600 shares at $13.25 ($367K) on 2016-05-25, disclosed to the SEC on 2016-05-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.25 | 12,300 | $163K | 44.4% |
| 2 | $12.53 | 16,300 | $204K | 55.6% |
| Total | $12.84 avg | 28,600 | $367K | 100% |
| Filing → |
| FLKS | BUY | 2016-11-08 | $51K | — | Filing → |
| FLKS | BUY | 2016-11-07 | $51K | — | Filing → |
| FLKS | BUY | 2016-06-24 | $30K | — | Filing → |